SYNTHASE BIO - FINANCIAL MODELLING
Synthase Bio are developing and marketing a novel antioxidant enzyme for use in a variety of biological systems. Scarlatti developed a detailed financial model to assist the company’s first external fundraising and to strike an agreement with an international partner.